RecruitingNot ApplicableNCT07339189

HIV Suicide Prevention With AI-DBT

Piloting AI-Delivered Dialectical Behavioral Therapy for Suicide Prevention in Older Patients Living With HIV

Sponsor

Rutgers, The State University of New Jersey

Enrollment

50 participants

Start Date

Jan 7, 2026

Study Type

INTERVENTIONAL

Conditions

HIV Suicidal Ideation and Behavior AIDS (Acquired Immune Deficiency Syndrome)

Summary

One in four older persons living with HIV/AIDS (PLWHA) report at least one suicide attempt in their lifetime, and the risk for death by suicide is 100 times higher in PLWHA than in the general population. Currently, there are no behavioral interventions that specifically address suicide prevention for older PLWHA, despite their unique biopsychosocial and structural risk factors. Through this work, investigators will adapt Dialectical Behavior Therapy, an evidence-based intervention for suicide prevention, for patients with PLWHA to be delivered by an AI-powered conversational Agent developed by our industry partner, Empower Health. Investigators will then pilot test the feasibility, usability, acceptability and preliminary efficacy to improve self-efficacy to manage negative emotions in n=50 older adults living with HIV/AIDS.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether an AI-assisted version of Dialectical Behaviour Therapy (DBT) — a type of therapy that helps people manage intense emotions — can reduce suicidal thoughts and improve mental wellbeing in older adults living with HIV. **You may be eligible if...** - You are 50 or older and living with HIV - You have shown some signs of suicide risk (e.g., a score on a depression or suicide screening questionnaire, or expressed suicidal thoughts to your doctor) - You can read and communicate in English or Spanish - You are not at immediate risk of suicide (no plan to act within 48 hours) - You have a smartphone with internet access **You may NOT be eligible if...** - You have severe psychosis, severe substance use disorder, or significant cognitive difficulties that would prevent you from engaging with the program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAI-DBT

Participants will receive 14, 5 minute videos delivered 2x/week that describe DBT skills and tools. They will also receive the option of engaging in coaching sessions.